Aptamer specific for myeloid derived suppressor cells for the diagnosis of head and neck cancer from the oral rinse
骨髓源性抑制细胞特异性适体,用于通过口腔冲洗液诊断头颈癌
基本信息
- 批准号:10665377
- 负责人:
- 金额:$ 19.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-15 至 2025-03-14
- 项目状态:未结题
- 来源:
- 关键词:AgeAntibodiesAntigensBenignBiological AssayBiological MarkersBiopsyBloodCD44 geneCancer PatientCase/Control StudiesCellsCirculationClinicClinicalClinical ResearchCommunitiesDataDetectionDevelopmentDiagnosisDiagnostic testsDimensionsDiseaseEarly DiagnosisEnrollmentEpitopesGoalsHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and neck structureHeterogeneityHistologicHumanHuman PapillomavirusImmunologic SurveillanceInfiltrationInstitutionLabelLarynxLesionLigandsLipidsLiquid substanceMacrophageMalignant - descriptorMalignant NeoplasmsMedicalMonitorMorbidity - disease rateMouth NeoplasmsMyelogenousMyeloid CellsMyeloid-derived suppressor cellsNeoplasmsOligonucleotidesOperative Surgical ProceduresOralOral DiagnosisOral cavityOropharyngealOtolaryngologyPatientsPeptidesPhenotypePopulationPrognosisProteinsProteomicsRNARecording of previous eventsRecurrenceResistanceResolutionRibonucleasesRoleRunningSalivaSamplingSensitivity and SpecificitySideSiteSpecificityStructureSurface Plasmon ResonanceSurvival RateTechniquesTestingTherapeuticTimeTissuesToxinTumor EscapeTumor MarkersTumor PromotionTumor stageVertebral columnaptamerchemical synthesiscohortcombinatorialcostdiagnostic assaydiagnostic toolexperimental studyhead and neck cancer patienthuman diseasehypopharynxmalignant mouth neoplasmneoplasticneoplastic cellnoninvasive diagnosisnovel strategiespathogenpatient subsetsprospectiveproteomic signaturesynthetic antibodiestumortumor growthtumor initiationtumor microenvironmenttumor progressiontumorigenesis
项目摘要
The development of sensitive and specific diagnostic assays for the early detection of Head and Neck Cancer is
still an unmet medical need. Most assays being developed rely on a neoplastic cell biomarker often present in
only a proportion of neoplastic cells and/or a subset of patients with Head and Neck Squamous Cell carcinoma
(HNSCC). As such, the intrinsic heterogeneity of the neoplastic cell within a single patient and across patients
de facto limits the sensitivity of these assays. To overcome this problem, we propose to monitor HNSCC
presence in the oral rinse using RNA aptamers that recognize tumor-infiltrating myeloid cells. These cells
infiltrate the lesion in high numbers and early during tumorigenesis, participate in tumor initiation and
progression, and predict recurrence in HNSCC. Additionally, these cells are quickly renewed in the tumor
microenvironment and release their content in the tumor microenvironment and nearby fluid.
We identified four RNA aptamers that recognize myeloid derived suppressor cells and macrophages in the
HNSCC tumor but not the myeloid counterparts in the blood or healthy tissues in all patients evaluated.
Additionally, our feasibility and proof of principle experiments indicate that these aptamers might discriminate
oral rinses of patients with head and neck cancers from those of healthy donors. We propose to test the
hypothesis that MDSC-specific aptamers used in linear surface plasmon resonance (LSPR) experiments can
detect HNSCC from the oral rinse with high sensitivity and specificity. We will first optimize the assay using
samples already banked in our institution. Then, we will perform a prospective clinical study in which we will test
oral rinses from 150 patients with biopsy-proven HNSCC (all stage, all sites) and 150 age-matched healthy
donors. In particular, we will compare side-by-side the sensitivity and specificity of LSPR assays using as ligand
either our MDSC specific aptamers or an antibody against CD44, a marker strongly associated with HNSCC that
is being developed for HNSCC diagnosis from the oral rinse with promising results.
In summary, we propose a novel approach for the early diagnosis of HNSCC, a disease often diagnosed only
in advanced stages when the prognosis is poor, and the treatment morbidity is high. Should our hypothesis be
true, we anticipate that assays based on the presence of MDSC may aid in detecting this malignancy at earlier
stages when treatments are most effective and less invasive.
发展灵敏和特异的诊断方法用于头颈癌的早期检测,
这是一个尚未满足的医疗需求。正在开发的大多数检测方法依赖于肿瘤细胞生物标志物,通常存在于
仅一部分肿瘤细胞和/或一部分头颈鳞状细胞癌患者
(HNSCC)。因此,单个患者内和患者间肿瘤细胞的内在异质性
事实上限制了这些测定的灵敏度。为了解决这个问题,我们建议监测HNSCC
使用识别肿瘤浸润性骨髓细胞的RNA适体检测口腔冲洗液中的存在。这些细胞
在肿瘤发生的早期大量浸润病变,参与肿瘤的发生,
进展,并预测HNSCC复发。此外,这些细胞在肿瘤中迅速更新,
肿瘤微环境和附近的液体释放其内容物。
我们鉴定了四种RNA适体,它们识别骨髓来源的抑制细胞和巨噬细胞。
HNSCC肿瘤,但不是骨髓对应物在血液或健康组织中的所有患者进行了评估。
此外,我们的可行性和原理实验的证明表明,这些适体可以区分
头颈癌患者的口腔冲洗液来自健康捐赠者。我们建议测试
假设用于线性表面等离子体共振(LSPR)实验MDSC特异性适体可以
检测口腔冲洗液中的HNSCC,具有较高的灵敏度和特异性。我们将首先使用
样本已经储存在我们的机构。然后,我们将进行一项前瞻性临床研究,
来自150名活检证实的HNSCC患者(所有阶段,所有部位)和150名年龄匹配的健康人的口腔冲洗液
捐助者。特别是,我们将比较并排的灵敏度和特异性的LSPR测定使用作为配体
我们的MDSC特异性适体或针对CD 44的抗体,CD 44是与HNSCC强烈相关的标志物,
正在开发用于从口腔冲洗液中诊断HNSCC,具有有希望的结果。
总之,我们提出了一种新的方法,用于早期诊断HNSCC,这种疾病通常只诊断出
晚期预后差,治疗病死率高。我们的假设应该是
的确,我们预期基于MDSC存在的检测可能有助于在早期发现这种恶性肿瘤。
治疗最有效和侵入性最小的阶段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth J Franzmann其他文献
Elizabeth J Franzmann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth J Franzmann', 18)}}的其他基金
Optical imaging of a CD44-based oral-rinse with fluorescent detection to visualize oral cancer
基于 CD44 的口腔冲洗液的光学成像与荧光检测以可视化口腔癌
- 批准号:
9047943 - 财政年份:2016
- 资助金额:
$ 19.19万 - 项目类别:
Salivary Soluble Markers in Head and Neck Cancer
头颈癌中唾液可溶性标记物
- 批准号:
7435255 - 财政年份:2007
- 资助金额:
$ 19.19万 - 项目类别:
Salivary Soluble Markers in Head and Neck Cancer
头颈癌中唾液可溶性标记物
- 批准号:
7622578 - 财政年份:2007
- 资助金额:
$ 19.19万 - 项目类别:
Salivary Soluble Markers in Head and Neck Cancer
头颈癌中唾液可溶性标记物
- 批准号:
7680965 - 财政年份:2007
- 资助金额:
$ 19.19万 - 项目类别:
Salivary Soluble Markers in Head and Neck Cancer
头颈癌中的唾液可溶性标记物
- 批准号:
7847071 - 财政年份:2007
- 资助金额:
$ 19.19万 - 项目类别:
Salivary Soluble Markers in Head and Neck Cancer
头颈癌中的唾液可溶性标记物
- 批准号:
8136842 - 财政年份:2007
- 资助金额:
$ 19.19万 - 项目类别:
Salivary Soluble Markers in Head and Neck Cancer
头颈癌中唾液可溶性标记物
- 批准号:
7262174 - 财政年份:2007
- 资助金额:
$ 19.19万 - 项目类别:
Salivary Soluble CD44: A Molecular Marker for Head and *
唾液可溶性 CD44:头部和 * 的分子标记
- 批准号:
6862772 - 财政年份:2004
- 资助金额:
$ 19.19万 - 项目类别:
Salivary Soluble CD44: A Molecular Marker for HNSCC
唾液可溶性 CD44:HNSCC 的分子标记
- 批准号:
6783728 - 财政年份:2004
- 资助金额:
$ 19.19万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 19.19万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 19.19万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 19.19万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 19.19万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 19.19万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 19.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 19.19万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 19.19万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 19.19万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 19.19万 - 项目类别:
Standard Grant